Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Evommune, Inc. (NYSE: EVMN)
EVMN Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-10.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
128.70%
EVMN Stock Analysis
EVMN
PE Ratio:
EVMN
PEG Ratio:
Not Available
EVMN
Forward EPS Growth (12 month):
0.00%
EVMN
PS Ratio:
21.5
EVMN
PSG Ratio:
Not Available
EVMN
Forward Revenue Growth (12 month):
0.00%
EVMN Articles
No data was found